Top compounds associated with response to CARD19


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.12 0.0001
mRNA STF-31 CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.11 0.0002
mRNA XMD15-27 GDSC1000 pan-cancer AAC 0.13 0.0002
mRNA PD-0325901 CCLE pan-cancer AAC 0.17 0.0002
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.0002
mRNA LY317615 GDSC1000 pan-cancer AAC 0.13 0.0002
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA SRT-1720 CTRPv2 pan-cancer AAC -0.14 0.0003
Download CSV